| Market Cap | 430K 377K 347K 325K 610K 40.55M 623K 4.18M 1.62M 20.04M 1.61M 1.58M 69.49M | P/E 2018 |
-21.3x | P/E 2019 | -0.95x |
|---|---|---|---|---|---|
| Enterprise Value | 1.53M 1.34M 1.23M 1.15M 2.17M 144M 2.21M 14.82M 5.74M 71.15M 5.73M 5.61M 247M | EV / Sales 2018 |
949,389,161x | EV / Sales 2019 | 25,985,979x |
| Free-Float |
54.43% | Yield 2018 * |
-
| Yield 2019 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 15K | |
| +6.65% | +8.89% | +50.93% | +165.06% | 1,006B | |
| +3.49% | +9.66% | +66.85% | +55.01% | 589B | |
| +1.34% | +7.05% | +31.82% | +82.46% | 430B | |
| -0.66% | +5.11% | +29.26% | +21.27% | 331B | |
| +1.82% | +8.19% | +41.15% | +26.80% | 288B | |
| +0.22% | +6.75% | +31.51% | +42.02% | 285B | |
| +0.73% | +8.53% | -26.22% | -40.85% | 213B | |
| +1.28% | +3.52% | +27.86% | +58.80% | 190B | |
| +2.21% | +1.21% | +17.43% | +65.07% | 154B | |
| Average | +1.61% | +5.96% | +30.07% | +52.85% | 387.31B | |
| Weighted average by Cap. | +2.91% | +5.38% | +39.36% | +78.34% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 0.05 0.05 0.04 0.04 0.07 4.84 0.07 0.5 0.19 2.39 0.19 0.19 8.3 | 0.3 0.27 0.25 0.23 0.43 28.6 0.44 2.95 1.14 14.14 1.14 1.11 49.02 |
| Net income | -2.23M -1.95M -1.8M -1.69M -3.16M -210M -3.23M -21.65M -8.38M -104M -8.37M -8.19M -360M | -6.85M -6M -5.53M -5.18M -9.71M -646M -9.91M -66.5M -25.73M -319M -25.71M -25.15M -1.11B |
| Net Debt | -161K -141K -130K -122K -228K -15.15M -233K -1.56M -604K -7.49M -603K -590K -25.96M | 1.1M 961K 886K 830K 1.56M 103M 1.59M 10.65M 4.12M 51.11M 4.12M 4.03M 177M |
Employees
-
Sector
Pharmaceuticals
